Chrousos syndrome: A seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes

European Journal of Clinical Investigation

Volumn 40, Issue 10, 2010, Pages 932-942

  Charmandari, Evangelia ^a,b,c   Kino, Tomoshige ^c  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Glucocorticoid receptor; glucocorticoid signal transduction; primary generalized glucocorticoid resistance

Indexed keywords

CALCITRIOL; CELL NUCLEUS RECEPTOR; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID; STEROID HORMONE;

ADRENAL DISEASE; ANDROGENESIS; CHROUSOS SYNDROME; CLINICAL FEATURE; FAMILIAL DISEASE; GENE MUTATION; GENETIC DRIFT; GR GENE; HUMAN; HYDROCORTISONE RELEASE; HYPERALDOSTERONISM; HYPERANDROGENISM; NONHUMAN; PHYLOGENY; PLATYRRHINI; PRIMATE; PRIORITY JOURNAL; RARE DISEASE; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN;

ANIMALS; GLUCOCORTICOIDS; HUMANS; MUTATION; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 77956544188     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02336.x     Document Type: Review

References (39)

1. Chrousos GP, Vingerhoeds A, Brandon D, Eil C, Pugeat M, DeVroede M et al. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest 1982 69 : 1261 1269.
2. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993 119 : 1113 1124.
3. Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 2008 93 : 1563 1572.
4. Nader N, Bachrach BE, Hurt DE, Gajula S, Pittman A, Lescher R et al. A novel point mutation in the helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain. J Clin Endocrinol Metab 2010 95 : 2281 2285.
5. McMahon SK, Pretorius CJ, Ungerer JP, Salmon NJ, Conwell LS, Pearen MA et al. Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 2010 95 : 297 302.
6. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS et al. 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004 25 : 831 866.
7. Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2 deficiency. Endocr Rev 1993 14 : 577 593.
8. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity. Endocr Rev 1996 17 : 221 244.
9. Chrousos GP, Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005 304 : pe48.
10. Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 1996 108 : 296 307.
11. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 1991 87 : 680 686.
12. Karl M, Lamberts SW, Detera-Wadleigh SD, Encio IJ, Stratakis CA, Hurley DM et al. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 1993 76 : 683 689.
13. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 1993 91 : 1918 1925.
14. Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 2001 86 : 5600 5608.
15. Ruiz M, Lind U, Gafvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 2001 55 : 363 371.
16. Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA et al. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 2002 87 : 1805 1809.
17. Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 2002 87 : 2658 2667.
18. Charmandari E, Kino T, Vottero A, Souvatzoglou E, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission and clinical phenotype. J Clin Endocrinol Metab 2004 89 : 1939 1949.
19. Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K et al. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 2005 90 : 3696 3705.
20. Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance. JClin Endocrinol Metab 2006 91 : 1535 1543.
21. Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K et al. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 2007 92 : 3986 3990.
22. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995 9 : 1608 1621.
23. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ et al. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 1999 19 : 1025 1037.
24. Dahlman-Wright K, Wright A, Gustafsson JA, Carlstedt-Duke J. Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 1991 266 : 3107 3112.
25. Kino T, Liou SH, Charmandari E, Chrousos GP. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. Mol Med 2004 12 : 80 8.
26. Thornton JW. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci U S A 2001 98 : 5671 5676.
27. Thornton JW, Need E, Crews D. Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 2003 301 : 1714 1717.
28. Bridgham JT, Carroll SM, Thornton JW. Evolution of hormone-receptor complexity by molecular exploitation. Science 2006 312 : 97 101.
29. Chrousos GP, Renquist D, Brandon D, Eil C, Pugeat M, Vigersky R et al. Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci U S A 1982 79 : 2036 2040.
30. Chrousos GP. (discussion) In: Lipsett MB, Chrousos GP, Brandon DD, Tomita M, Loriaux DL. The defective glucocorticoid receptor in man and nonhuman primates. Recent Prog Horm Res 1985 41 : 199 247.
31. Chrousos GP, Loriaux DL, Lipsett MB, eds. Steroid Hormone Resistance: Mechanisms and Clinical Aspects. Advances in Experimental Medicine and Biology, Vol. 196. New York : Plenum Press 1986.
32. Westberry JM, Sadosky PW, Hubler TR, Gross KL, Scammell JG. Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51. J Steroid Biochem Mol Biol 2006 3 : 34 41.
33. Chrousos GP. A new "New" syndrome in the New World: is multiple postreceptor steroid hormone resistance due to a coregulator defect? J Clin Endocrinol Metab 1999 84 : 4450 4453.
34. Chrousos GP, Kino T. Glucocorticoid signaling in the cell: expanding clinical implications to complex human behavioral and somatic disorders. In: Glucocorticoids and mood: clinical manifestations, risk factors, and molecular mechanisms. Ann N Y Acad Sci 2009 1179 : 153 166.
35. Charmandari E, Ichijo T, Jubiz W, Baid S, Zachman K, Chrousos GP et al. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J Clin Endocrinol Metab 2008 93 : 4963 4968.
36. Ferriman D, Gallwey J. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961 83 : 2694 2698.
37. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969 44 : 291 303.
38. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970 45 : 13 24.
39. Huizenga NA, de Lange P, Koper JW, de Herder WW, Abs R, Kasteren JH et al. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J Clin Endocrinol Metab 2000 85 : 2076 2081.